These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 10535)
1. LSD and 2-bromo-LSD: comparison on effects on serotonergic neurones and on neurones in two serotonergic projection areas, the ventral lateral geniculate and amygdala. Aghajanian GK Neuropharmacology; 1976 Sep; 15(9):521-8. PubMed ID: 10535 [No Abstract] [Full Text] [Related]
2. Lysergic acid diethylamide and serotonin: a comparison of effects on serotonergic neurons and neurons receiving a serotonergic input. Haigler HJ; Aghajanian GK J Pharmacol Exp Ther; 1974 Mar; 188(3):688-99. PubMed ID: 4593245 [No Abstract] [Full Text] [Related]
3. A re-evaluation of the mode of action of 5-hydroxytryptamine on lateral geniculate neurones: comparison with catecholamines and LSD. Tebécis AK; Di Maria A Exp Brain Res; 1972 Apr; 14(5):480-93. PubMed ID: 4340071 [No Abstract] [Full Text] [Related]
4. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei. Larson AA; Chinn C; Proudfit HK; Anderson EG J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778 [TBL] [Abstract][Full Text] [Related]
5. Effects of quipazine on pre- and postsynaptic serotonin receptors: single cell studies in the rat CNS. Blier P; de Montigny C Neuropharmacology; 1983 Apr; 22(4):495-9. PubMed ID: 6856049 [TBL] [Abstract][Full Text] [Related]
6. Denervation supersensitivity to serotonin in rat forebrain: single cell studies. Wang RY; de Montigny C; Gold BI; Roth RH; Aghajanian GK Brain Res; 1979 Dec; 178(2-3):479-97. PubMed ID: 509215 [TBL] [Abstract][Full Text] [Related]
7. Antagonism by LSD to effects of 5-HT on single neurones. Boakes RJ; Bradley PB; Briggs I; Dray A Brain Res; 1969 Oct; 15(2):529-31. PubMed ID: 5344384 [No Abstract] [Full Text] [Related]
8. LSD: effects on sleep patterns and spiking activity in the lateral geniculate nucleus. Stern WC; Morgane PJ; Bronzine JD Brain Res; 1972 Jun; 41(1):199-204. PubMed ID: 5036037 [No Abstract] [Full Text] [Related]
9. Pharmacological studies upon neurones of the lateral geniculate nucleus of the cat. CURTIS DR; DAVIS R Br J Pharmacol Chemother; 1962 Apr; 18(2):217-46. PubMed ID: 13882768 [TBL] [Abstract][Full Text] [Related]
10. Distortions of vision and pain: two functional facets of D-lysergic acid diethylamide. Williams JM Percept Mot Skills; 1979 Oct; 49(2):499-528. PubMed ID: 229462 [TBL] [Abstract][Full Text] [Related]
11. QSAR of agents involved in serotonin and LSD binding sites. Chan YL; Lien EJ; Shih JC NIDA Res Monogr; 1978; (22):103-13. PubMed ID: 30904 [No Abstract] [Full Text] [Related]
12. Is 2-bromo-D-lysergic acid diethylamide (BOL) an allosteric antagonist of serotonergic receptors in rabbit atria? Xu Z; Purdy RE Proc West Pharmacol Soc; 1988; 31():181-3. PubMed ID: 2905465 [No Abstract] [Full Text] [Related]
14. Hyperpolarization of serotonergic neurons by serotonin and LSD: studies in brain slices showing increased K+ conductance. Aghajanian GK; Lakoski JM Brain Res; 1984 Jul; 305(1):181-5. PubMed ID: 6331598 [TBL] [Abstract][Full Text] [Related]
15. Effects of LSD on Ca++ currents in central 5-HT-containing neurons: 5-HT1A receptors may play a role in hallucinogenesis. Penington NJ; Fox AP J Pharmacol Exp Ther; 1994 Jun; 269(3):1160-5. PubMed ID: 8014859 [TBL] [Abstract][Full Text] [Related]
16. Actions of D-lysergic acid diethylamide (LSD) and its derivatives on 5-hydroxytryptamine receptors in the isolated uterine smooth muscle of the rat. Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H Eur J Pharmacol; 1977 Oct; 45(4):341-8. PubMed ID: 923645 [No Abstract] [Full Text] [Related]
17. Antagonism of 5-hydroxytryptamine by LSD 25 in the central nervous system: a possible neuronal basis for the actions of LSD 25. Boakes RJ; Bradley PB; Briggs I; Dray A Br J Pharmacol; 1970 Oct; 40(2):202-18. PubMed ID: 5492893 [TBL] [Abstract][Full Text] [Related]
18. (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist. Burris KD; Breeding M; Sanders-Bush E J Pharmacol Exp Ther; 1991 Sep; 258(3):891-6. PubMed ID: 1679849 [TBL] [Abstract][Full Text] [Related]
19. Effects of repeated administration of the monoamine oxidase inhibitor phenelzine on the discriminability of d-lysergic acid diethylamide (LSD) and 1-(m-trifluoromethylphenyl) piperazine (TFMPP). Cunningham KA; Carroll BA; Appel JB Psychopharmacology (Berl); 1986; 89(1):134-5. PubMed ID: 3090587 [TBL] [Abstract][Full Text] [Related]
20. Separation of tolerance to the behavioral effects of LSD from changes in serotonin receptor binding in cats. Trulson ME Eur J Pharmacol; 1985 May; 111(3):385-8. PubMed ID: 4018133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]